CRNX
Price
$29.96
Change
-$0.45 (-1.48%)
Updated
Jun 27 closing price
Capitalization
2.81B
40 days until earnings call
LENZ
Price
$30.18
Change
+$0.07 (+0.23%)
Updated
Jun 27 closing price
Capitalization
848.61M
Interact to see
Advertisement

CRNX vs LENZ

Header iconCRNX vs LENZ Comparison
Open Charts CRNX vs LENZBanner chart's image
Crinetics Pharmaceuticals
Price$29.96
Change-$0.45 (-1.48%)
Volume$1.64M
Capitalization2.81B
LENZ Therapeutics
Price$30.18
Change+$0.07 (+0.23%)
Volume$1.29M
Capitalization848.61M
CRNX vs LENZ Comparison Chart in %
Loading...
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LENZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRNX vs. LENZ commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRNX is a Buy and LENZ is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (CRNX: $29.96 vs. LENZ: $30.18)
Brand notoriety: CRNX and LENZ are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRNX: 213% vs. LENZ: 459%
Market capitalization -- CRNX: $2.81B vs. LENZ: $848.61M
CRNX [@Biotechnology] is valued at $2.81B. LENZ’s [@Biotechnology] market capitalization is $848.61M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRNX’s FA Score shows that 0 FA rating(s) are green whileLENZ’s FA Score has 0 green FA rating(s).

  • CRNX’s FA Score: 0 green, 5 red.
  • LENZ’s FA Score: 0 green, 5 red.
According to our system of comparison, LENZ is a better buy in the long-term than CRNX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRNX’s TA Score shows that 2 TA indicator(s) are bullish while LENZ’s TA Score has 5 bullish TA indicator(s).

  • CRNX’s TA Score: 2 bullish, 6 bearish.
  • LENZ’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, LENZ is a better buy in the short-term than CRNX.

Price Growth

CRNX (@Biotechnology) experienced а -1.77% price change this week, while LENZ (@Biotechnology) price change was +0.80% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

CRNX is expected to report earnings on Aug 08, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRNX($2.81B) has a higher market cap than LENZ($849M). LENZ YTD gains are higher at: 4.538 vs. CRNX (-41.404). LENZ has higher annual earnings (EBITDA): -59.36M vs. CRNX (-373.49M). CRNX has more cash in the bank: 1.27B vs. LENZ (194M). LENZ has less debt than CRNX: LENZ (1.18M) vs CRNX (50.8M). CRNX has higher revenues than LENZ: CRNX (760K) vs LENZ (0).
CRNXLENZCRNX / LENZ
Capitalization2.81B849M331%
EBITDA-373.49M-59.36M629%
Gain YTD-41.4044.538-912%
P/E RatioN/A45.68-
Revenue760K0-
Total Cash1.27B194M657%
Total Debt50.8M1.18M4,298%
FUNDAMENTALS RATINGS
CRNX: Fundamental Ratings
CRNX
OUTLOOK RATING
1..100
61
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
PROFIT vs RISK RATING
1..100
67
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRNXLENZ
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
87%
Momentum
ODDS (%)
Bearish Trend 3 days ago
81%
Bullish Trend 3 days ago
76%
MACD
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
78%
Bullish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
86%
Advances
ODDS (%)
N/A
Bullish Trend 3 days ago
83%
Declines
ODDS (%)
Bearish Trend 3 days ago
79%
Bearish Trend 14 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 10 days ago
86%
Bearish Trend 3 days ago
82%
Aroon
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 3 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LENZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JAMRX91.680.74
+0.81%
Janus Henderson Research T
MWOCX49.240.33
+0.67%
MFS Global Growth C
PADEX22.060.10
+0.46%
Putnam Dynamic Asset Allocation Gr R5
BMIDX17.810.08
+0.45%
Brown Advisory Mid-Cap Growth Investor
BRSYX14.290.06
+0.42%
MFS Blended Research Small Cap Eq R6

CRNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRNX has been loosely correlated with XNCR. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if CRNX jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRNX
1D Price
Change %
CRNX100%
-0.10%
XNCR - CRNX
58%
Loosely correlated
-3.10%
TRDA - CRNX
57%
Loosely correlated
-1.57%
DYN - CRNX
56%
Loosely correlated
-4.78%
IDYA - CRNX
55%
Loosely correlated
-4.13%
RVMD - CRNX
55%
Loosely correlated
-1.52%
More

LENZ and

Correlation & Price change

A.I.dvisor indicates that over the last year, LENZ has been loosely correlated with BEAM. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if LENZ jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LENZ
1D Price
Change %
LENZ100%
+0.23%
BEAM - LENZ
46%
Loosely correlated
-1.98%
CRNX - LENZ
45%
Loosely correlated
-0.10%
ZYME - LENZ
45%
Loosely correlated
+0.81%
ATXS - LENZ
45%
Loosely correlated
N/A
ARWR - LENZ
45%
Loosely correlated
+0.06%
More